.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Cipla
Cerilliant
Covington
Teva
Deloitte
Moodys
Argus Health
Boehringer Ingelheim
Farmers Insurance

Generated: December 17, 2017

DrugPatentWatch Database Preview

Claims for Patent: 4,393,078

« Back to Dashboard

Claims for Patent: 4,393,078

Title: Bupropion and ethanol
Abstract:This invention relates a method of restoring slowed mental ability in humans caused by ethanol by treatment with the compound of formula I ##STR1## or a pharmaceutically acceptable acid addition salt thereof in a non-toxic, effective therapeutic amount to a human in need thereof.
Inventor(s): Peck; Anthony W. (Bromley, GB2)
Assignee: Burroughs Wellcome Co. (Research Triangle Park, NC)
Application Number:06/358,354
Patent Claims: 1. A method of reversing the impaired mental alertness effects of ethanol in a human, which comprises administering to a human who has consumed alcohol an effective, non-toxic amount of the compound of formula (I) ##STR3## or a pharmaceutically acceptable acid addition salt thereof to reverse the mental alertness effects of ethanol in the human.

2. The method of claim 1 in which a pharmaceutically acceptable acid addition salt thereof is administered.

3. The method of claim 2 in which the salt is the hydrochloride salt.

4. The method of claim 1, 2 or 3 in which the compound or salt is administered in a pharmaceutically acceptable carrier therefor.

5. The method of claim 1, 2, 3 or 4 in which the compound or salt is administered orally.

6. The method of claim 5 in which the compound or salt is administered in a pharmaceutically acceptable carrier therefor.

7. The method of claim 1 in which the compound or salt is administered in a capsule or tablet containing a pharmaceutically acceptable carrier.

8. The method of claim 4 in which the pharmaceutically acceptable acid addition salt is administered.

9. The method of claim 5 in which the salt is hydrochloride.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Cantor Fitzgerald
Cerilliant
Johnson and Johnson
Fuji
Dow
US Department of Justice
Accenture
Chinese Patent Office
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot